Sec Form 4 Filing - CORASANTI JOSEPH J @ CONMED CORP - 2014-07-30

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person CORASANTI JOSEPH J 2. Issuer Name and Ticker or Trading Symbol CONMED CORP [ CNMD] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Former President & CEO (Last) (First) (Middle) 101 WINSHIP ROAD 3. Date of Earliest Transaction (MM/DD/YY) 07/30/2014 (Street) NEW HARTFORD, NY13413 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 07/30/2014 M 5,000 A $ 0 137,685 D Common Stock 07/30/2014 F 2,534 D $ 39.38 135,151 D Common Stock 07/30/2014 M 10,000 A $ 0 145,151 D Common Stock 07/30/2014 F 5,067 D $ 39.38 140,084 D Common Stock 07/30/2014 M 15,000 A $ 0 155,084 D Common Stock 07/30/2014 F 7,601 D $ 39.38 147,483 D Common Stock 07/30/2014 M 20,000 A $ 0 167,483 D Common Stock 07/30/2014 F 10,134 D $ 39.38 157,349 D Common Stock 07/30/2014 M 16,250 A $ 0 173,599 D Common Stock 07/30/2014 F 8,234 D $ 39.38 165,365 D Common Stock 07/30/2014 M 62,500 A $ 19.93 227,865 D Common Stock 07/30/2014 F 47,273 D $ 39.38 180,592 D Common Stock 07/30/2014 M 62,500 A $ 29.92 243,092 D Common Stock 07/30/2014 F 55,095 D $ 39.38 187,997 D Common Stock 07/30/2014 M 62,500 A $ 26.69 250,497 D Common Stock 07/30/2014 F 52,566 D $ 39.38 197,931 D Common Stock 07/30/2014 M 62,500 A $ 16.46 260,431 D Common Stock 07/30/2014 F 44,556 D $ 39.38 215,875 D Common Stock 07/30/2014 M 40,000 A $ 21.19 255,875 D Common Stock 07/30/2014 F 30,886 D $ 39.38 224,989 D Common Stock 07/30/2014 M 62,500 A $ 19.26 287,489 D Common Stock 07/30/2014 F 46,749 D $ 39.38 240,740 D Common Stock 07/30/2014 M 62,500 A $ 27.63 303,240 D Common Stock 07/30/2014 F 53,302 D $ 39.38 249,938 D Common Stock 07/30/2014 M 62,500 A $ 26.09 312,438 D Common Stock 07/30/2014 F 52,096 D $ 39.38 260,342 D Common Stock 07/30/2014 M 62,500 A $ 32.93 322,842 D Common Stock 07/30/2014 F 57,451 D $ 39.38 265,391 D Common Stock 07/30/2014 S 109,035 D $ 39.2483 ( 1 ) 156,356 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Rsus (restricted Stock Units) $ 0 07/30/2014 M 5,000 ( 2 )( 3 ) 06/01/2020 Common Stock 5,000 $ 0 0 D Rsus (restricted Stock Units) $ 0 07/30/2014 M 10,000 ( 2 )( 3 ) 06/01/2021 Common Stock 10,000 $ 0 0 D Rsus (restricted Stock Units) $ 0 07/30/2014 M 15,000 ( 2 )( 3 ) 06/01/2022 Common Stock 15,000 $ 0 0 D Rsus (restricted Stock Units) $ 0 07/30/2014 M 20,000 ( 2 )( 3 ) 06/01/2023 Common Stock 20,000 $ 0 0 D Rsus (restricted Stock Units) $ 0 07/30/2014 M 16,250 ( 2 )( 3 ) 06/01/2024 Common Stock 16,250 $ 0 0 D Sars (Stock Appreciation Rights) $ 19.93 07/30/2014 M 62,500 ( 3 )( 4 ) 05/16/2016 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 29.92 07/30/2014 M 62,500 ( 3 )( 5 ) 05/17/2017 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 26.69 07/30/2014 M 62,500 ( 3 )( 5 ) 06/01/2018 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 16.46 07/30/2014 M 62,500 ( 3 )( 6 ) 06/01/2019 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 21.19 07/30/2014 M 40,000 ( 3 )( 7 ) 10/30/2019 Common Stock 40,000 $ 0 0 D Sars (Stock Appreciation Rights) $ 19.26 07/30/2014 M 62,500 ( 3 )( 6 ) 06/01/2020 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 27.63 07/30/2014 M 62,500 ( 3 )( 6 ) 06/01/2021 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 26.09 07/30/2014 M 62,500 ( 3 )( 6 ) 06/01/2022 Common Stock 62,500 $ 0 0 D Sars (Stock Appreciation Rights) $ 32.93 07/30/2014 M 62,500 ( 3 )( 6 ) 06/01/2023 Common Stock 62,500 $ 0 0 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other CORASANTI JOSEPH J 101 WINSHIP ROAD NEW HARTFORD, NY13413 Former President & CEO Signatures Daniel S. Jonas for Joseph J. Corasanti by Power of Attorney 07/31/2014 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $39.35. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder. ( 2 )Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan, with the RSUs generally vesting over a five year period with the first 20% of the RSU's vesting one year after the grant date. ( 3 )According to Section 2(d) of the Separation and Release Agreement dated July 22, 2014, and attached as Exhibit 10.1 of the Form 8-K dated July 23, 2014, all of Mr. Joseph Corasanti's unvested RSUs and SARs accelerated, other than the 2014 SARS which were cancelled. ( 4 )The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period. ( 5 )The stock appreciation rights ("SARs") were granted under the Company's 2006 Stock Incentive Plan and generally vest in equal amounts over a five year period. ( 6 )The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period. ( 7 )The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a period with the first 20% tranche to vest on June 1, 2010 with each successive 20% tranche to vest on June 1 the following year.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.